Related references
Note: Only part of the references are listed.Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein-Mediated Drug-Drug Interactions in Healthy Volunteers
Takeshi Miyake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Identification of Glycochenodeoxycholate 3-O-glucuronide and Glycodeoxycholate 3-O-glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers
Mikko Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Exploring the Use of Serum-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides
A. David Rodrigues et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Drug-Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker-Informed Approach
Sumathy Mathialagan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI
Nicholas S. Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations
Kunal S. Taskar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Dose-Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs
Daiki Mori et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?
A. David Rodrigues et al.
DRUG METABOLISM AND DISPOSITION (2020)
Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature
A. David Rodrigues et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study
Arthur Bergman et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Physiologically-Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P-glycoprotein and Cytochrome P450 3A
Yukio Otsuka et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation
Christine M. Bowman et al.
DRUG METABOLISM AND DISPOSITION (2019)
A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes
Keith A. Riccardi et al.
DRUG METABOLISM AND DISPOSITION (2019)
Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1
Samantha Medwid et al.
DRUG METABOLISM AND DISPOSITION (2019)
Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans
Mingxiang Liao et al.
XENOBIOTICA (2019)
Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A
Erika Panfen et al.
DRUG METABOLISM AND DISPOSITION (2019)
Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo
Congrong Niu et al.
DRUG METABOLISM AND DISPOSITION (2019)
From Endogenous Compounds as Biomarkers to Plasma-Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational Pharmacokinetics-Absorption, Distribution, Metabolism, Excretion-Drug-Drug Interaction Science Finally Arrived?
David Rodrigues et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the Albumin-Mediated Hepatic Uptake Mechanism on the Basis of the Facilitated-Dissociation Model
Soo-Jin Kim et al.
DRUG METABOLISM AND DISPOSITION (2019)
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I
Shelby Barnett et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein Induction
Shinji Yamazaki et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin
Justin D. Lutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy-and Safety-Based Dose Adjustment Decision
Maciej J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance
Maciej J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3
Takashi Yoshikado et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP
Yushi Kashihara et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism
Yukina Fukuchi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport
Hye In Kim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Extended Clearance Classification System (ECCS) Informed Approach for Evaluating Investigational Drugs as Substrates of Drug Transporters
M. V. Varma et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease
Michael Murray et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin
Marta Johnson et al.
DRUG METABOLISM AND DISPOSITION (2017)
OCT1 Mediates Hepatic Uptake of Sumatriptan and Loss-of-Function OCT1 Polymorphisms Affect Sumatriptan Pharmacokinetics
J. Matthaei et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives
Yuzhuo Pan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice
Chise Tateno et al.
PLOS ONE (2015)
Beyond the ITC White Paper: Emerging Sciences in Drug Transporters and Opportunities for Drug Development
Yurong Lai et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers
Yumiko Akamine et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease
Anand K. Deo et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS
Sumio Ohtsuki et al.
DRUG METABOLISM AND DISPOSITION (2014)
Mass Spectrometry-Based Targeted Proteomics as a Tool to Elucidate the Expression and Function of Intestinal Drug Transporters
Stefan Oswald et al.
AAPS JOURNAL (2013)
ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
M. J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Medicinal Chemistry Design Principles for Liver Targeting Through OATP Transporters
Meihua Tu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Species differences in drug transporters and implications for translating preclinical findings to humans
Xiaoyan Chu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Demystifying Brain Penetration in Central Nervous System Drug Discovery
Li Di et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Application of Permeability-Limited Physiologically-Based Pharmacokinetic Models: Part II - Prediction of P-Glycoprotein Mediated Drug-Drug Interactions with Digoxin
Sibylle Neuhoff et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat Hepatocytes
Karelle Menochet et al.
DRUG METABOLISM AND DISPOSITION (2012)
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
Hannah M. Jones et al.
DRUG METABOLISM AND DISPOSITION (2012)
Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren
Tuija Tapaninen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer
Senthil Karunakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human metabolic individuality in biomedical and pharmaceutical research
Karsten Suhre et al.
NATURE (2011)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
Edward B. Mougey et al.
PHARMACOGENETICS AND GENOMICS (2009)
Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study
Wei Zhang et al.
CLINICAL THERAPEUTICS (2008)
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine
Mikael Oscarson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver
M Nishimura et al.
XENOBIOTICA (2005)
Share Paper
